BR9705157A - Derivados de 10,13,15-trioxatriciclo[9.2.1. 9.6]-pentadecanona, processo para a sua preparação e medicamentos que contêm estes compostos - Google Patents

Derivados de 10,13,15-trioxatriciclo[9.2.1. 9.6]-pentadecanona, processo para a sua preparação e medicamentos que contêm estes compostos

Info

Publication number
BR9705157A
BR9705157A BR9705157-8A BR9705157A BR9705157A BR 9705157 A BR9705157 A BR 9705157A BR 9705157 A BR9705157 A BR 9705157A BR 9705157 A BR9705157 A BR 9705157A
Authority
BR
Brazil
Prior art keywords
capsule
trioxatriciclo
pentadecanone
derivatives
compounds
Prior art date
Application number
BR9705157-8A
Other languages
English (en)
Inventor
Dagmar Hoeltje
Ulf Preuschoff
Christian Eeckhout
Emmil Finner
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR9705157A publication Critical patent/BR9705157A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PATENTE DE INVENçãO DE "NìVEL MULTIANGULAR", cujo corpo (1) é formado por base (2), que em sua porção inferior apresenta superfície plana (3) e em sua porção superior possui ressalto (4), que, centralmente, é formado por rasgo superior (5) e abertura lateral (6) onde aloca-se cápsula (7), que é constituída em sua porção interna por anel octaédrico (8), onde tem-se introduzido fluído (9) que possui bolha de ar (10), sendo que, a porção externa da cápsula (10) apresenta escala graduada (11). Dita invenção possui como opção construtiva um corpo (1) formado por base (2) que em sua porção inferior apresenta superfície plana (2) e em sua porção superior possui ressalto (4) onde aloca-se centralmente, cápsula (12) que, em sua porção interna, possui a introdução do fluído (9) ao nível de 50% da capacidade volumétrica interna da mesma, sendo que dita cápsula (12) possui, em sua porção externa, escala graduada (13).
BR9705157-8A 1996-10-24 1997-10-24 Derivados de 10,13,15-trioxatriciclo[9.2.1. 9.6]-pentadecanona, processo para a sua preparação e medicamentos que contêm estes compostos BR9705157A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19644195A DE19644195A1 (de) 1996-10-24 1996-10-24 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BR9705157A true BR9705157A (pt) 1999-09-28

Family

ID=7809858

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9705143-8A BR9705143A (pt) 1996-10-24 1997-10-24 Derivados de 10,13,15-trioxatriciclo [9.2.1.1(9.6)] -pentadecanona, processo para a sua preparação e medicamentos que contém estes compostos
BR9705157-8A BR9705157A (pt) 1996-10-24 1997-10-24 Derivados de 10,13,15-trioxatriciclo[9.2.1. 9.6]-pentadecanona, processo para a sua preparação e medicamentos que contêm estes compostos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9705143-8A BR9705143A (pt) 1996-10-24 1997-10-24 Derivados de 10,13,15-trioxatriciclo [9.2.1.1(9.6)] -pentadecanona, processo para a sua preparação e medicamentos que contém estes compostos

Country Status (27)

Country Link
US (1) US5912235A (pt)
EP (1) EP0838469B1 (pt)
JP (1) JP4175682B2 (pt)
KR (1) KR100466495B1 (pt)
CN (1) CN1093133C (pt)
AR (1) AR009809A1 (pt)
AT (1) ATE211745T1 (pt)
AU (1) AU726092B2 (pt)
BR (2) BR9705143A (pt)
CA (1) CA2219311C (pt)
CZ (1) CZ291768B6 (pt)
DE (2) DE19644195A1 (pt)
DK (1) DK0838469T3 (pt)
DZ (1) DZ2322A1 (pt)
ES (1) ES2170318T3 (pt)
HK (1) HK1010885A1 (pt)
HU (1) HU222540B1 (pt)
IL (1) IL121969A (pt)
MX (1) MX9707974A (pt)
NO (1) NO308362B1 (pt)
NZ (1) NZ328979A (pt)
PL (1) PL184693B1 (pt)
PT (1) PT838469E (pt)
RU (1) RU2181727C2 (pt)
SK (1) SK283114B6 (pt)
UA (1) UA44310C2 (pt)
ZA (1) ZA979059B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100239A (en) * 1996-11-26 2000-08-08 Chugai Seiyaku Kabushiki Kaisha 13-membered ring macrolide compound, medicine containing the same, and process for producing the same
DE60027015T2 (de) 2000-08-17 2006-10-05 The Kitasato Institute Pseudoerythromycin-derivate
JP2003007917A (ja) * 2001-06-19 2003-01-10 Sanyo Electric Co Ltd 回路装置の製造方法
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia
ES2338789T3 (es) 2003-06-18 2010-05-12 Tranzyme Pharma Inc. Antagonistas macrociclicos del receptor de motilina.
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
US20080312209A1 (en) 2005-07-12 2008-12-18 Glaxo Group Limited Piperazine Heteroaryl Derivatives as Gpr38 Agonists
PT1907374E (pt) * 2005-07-26 2012-11-05 Glaxo Group Ltd Derivados de benzilpiperazina úteis para o tratamento de doenças gastrointestinais
BRPI0619556A2 (pt) * 2005-12-08 2011-10-04 Pfizer processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina
CA2655540A1 (en) 2006-06-28 2008-01-03 Glaxo Group Limited Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
CN101528765B (zh) 2006-09-11 2015-04-22 欧塞拉治疗有限公司 用于治疗胃肠动力障碍病症的促胃动素受体的大环拮抗剂
CN102317280B (zh) 2009-02-27 2014-07-23 拉夸里亚创药株式会社 具有胃动素受体激动活性的羟基吲哚衍生物
US9682126B2 (en) * 2013-03-25 2017-06-20 Zeria Pharmaceutical Co., Ltd. Postprandial gastrokinetic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
CA2219311C (en) 2007-09-04
SK141997A3 (en) 1998-05-06
HUP9701660A3 (en) 1998-08-28
CZ310697A3 (cs) 1998-06-17
EP0838469B1 (de) 2002-01-09
DE59705964D1 (de) 2002-02-14
JPH10130297A (ja) 1998-05-19
KR100466495B1 (ko) 2005-05-27
ES2170318T3 (es) 2002-08-01
IL121969A0 (en) 1998-03-10
HU9701660D0 (en) 1997-12-29
DK0838469T3 (da) 2002-03-18
UA44310C2 (uk) 2002-02-15
HU222540B1 (hu) 2003-08-28
ZA979059B (en) 1998-05-07
BR9705143A (pt) 2000-12-12
PT838469E (pt) 2002-05-31
AR009809A1 (es) 2000-05-03
AU4278897A (en) 1998-04-30
DE19644195A1 (de) 1998-04-30
SK283114B6 (sk) 2003-02-04
CA2219311A1 (en) 1998-04-24
NO308362B1 (no) 2000-09-04
MX9707974A (es) 1998-04-30
RU2181727C2 (ru) 2002-04-27
CN1093133C (zh) 2002-10-23
HUP9701660A2 (hu) 1998-05-28
US5912235A (en) 1999-06-15
IL121969A (en) 2000-06-29
CZ291768B6 (cs) 2003-05-14
ATE211745T1 (de) 2002-01-15
JP4175682B2 (ja) 2008-11-05
DZ2322A1 (fr) 2002-12-28
NO974934D0 (no) 1997-10-24
HK1010885A1 (en) 1999-07-02
NZ328979A (en) 1998-10-28
PL322802A1 (en) 1998-04-27
PL184693B1 (pl) 2002-12-31
EP0838469A1 (de) 1998-04-29
CN1186808A (zh) 1998-07-08
KR19980032626A (ko) 1998-07-25
AU726092B2 (en) 2000-11-02
NO974934L (no) 1998-04-27

Similar Documents

Publication Publication Date Title
BR9705157A (pt) Derivados de 10,13,15-trioxatriciclo[9.2.1. 9.6]-pentadecanona, processo para a sua preparação e medicamentos que contêm estes compostos
Del Brutto et al. Albendazole therapy for subarachnoid and ventricular cysticercosis: case report
GB0016819D0 (en) Improvements in or relating to delivery capsules
BR0208887A (pt) Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2
NZ509489A (en) Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
HUP0101831A2 (hu) Szulfonamidszármazékok mint aszpartil-proteáz inhibitorok prodrugjai és ezeket tartalmazó gyógyszerkészítmények
BRPI0314287B8 (pt) processo de manufatura de um sistema de distribuição
DE69905712D1 (de) Verwendung von indigoähnlichen bisindolen zur herstellung eines arzneimittels zur hemmung cyclin abhängiger kinasen
BRPI0209825B8 (pt) Sensor de combustível
BR0117063A (pt) Uso de ciclopamina no tratamento de carcinoma de células basais e outros tumores
BR9911650A (pt) Reator de taylor para transformações de substâncias, em cujo decurso inicia-se uma mudança da viscosidade upsilon do meio de reação
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
ATE384673T1 (de) Applikator für fluide substanzen für den einsatz in der medizin und/oder kosmetik
GB2372454B (en) Medical respiratory apparatus
IT1231260B (it) Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo
EA200300452A1 (ru) Способ и устройство для перемешивания текучих сред
HUP9701112A2 (hu) Antiflatulenst tartalmazó töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
BR0208216A (pt) Distribuidor de fluido
GB2155436A (en) Measuring device
BR0015025A (pt) Solução oral contendo galantamina e um agente adoçante
IL94601A (en) Pharmaceutical preparations containing neptofidil for the treatment of dysuria
MC200066A1 (fr) Forme posologique pharmaceutique portant une signalétique indiquant une parfaite innocuité en cas degrossesse
CN218663177U (zh) 一种液体取药瓶
CN211675570U (zh) 引流瓶
BR9801909A (pt) Encapsulador para medicamentos, modular e de funcionamento manual e/ou semi-automático.

Legal Events

Date Code Title Description
HHB Publication of an application: rectification
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]